Science Explorer Interactive view Map
Topic · Emergency Medicine

HIV-related health complications and treatments

HIV-related health complications and treatments is a research topic within Emergency Medicine. Science Explorer counts 24k research works in it since 1953. 21.7% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the impact of HIV infection, antiretroviral therapy, inflammation, metabolic abnormalities, and aging on cardiovascular health. It covers a wide range of topics including myocardial infarction, lipodystrophy, bone mineral density, insulin resistance, and the association between HIV infection and various cardiovascular diseases. The research also delves into the effects of specific antiretroviral drugs on cardiovascular risk factors and provides insights into the management of metabolic complications associated with HIV-1 infection.

  • HIV Infection
  • Cardiovascular Disease
  • Antiretroviral Therapy
  • Inflammation
  • Metabolic Abnormalities
  • Aging
  • Myocardial Infarction
  • Lipodystrophy
  • Bone Mineral Density
  • Insulin Resistance
Research works
24k
fractional, since 1953
In the world top 10%
5.1k
per year above
Top-10% rate
21.7%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+7%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead HIV-related health complications and treatments research?

By volume, the United States and China publish the most (1.2k and 344 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.2k works
  2. 2 China 344 works
  3. 3 Brazil 192 works
  4. 4 United Kingdom 162 works
  5. 5 South Africa 157 works
  6. 6 Spain 157 works
  7. 7 India 146 works
  8. 8 Italy 143 works
  9. 9 Canada 99 works
  10. 10 Nigeria 97 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 45.1%China: 12.6%Brazil: 7.0%United Kingdom: 5.9%6 others listed: 29.3%45%largest
United States1,230 · 45.1%China344 · 12.6%Brazil192 · 7.0%United Kingdom162 · 5.9%6 others listed799 · 29.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead HIV-related health complications and treatments research?

By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most HIV-related health complications and treatments research, followed by Johns Hopkins University and University of California, San Francisco.

By volume, 2022–2025

  1. 1 University of North Carolina at Chapel HillUnited States 90 works
  2. 2 Johns Hopkins UniversityUnited States 34 works
  3. 3 University of California, San FranciscoUnited States 26 works
  4. 4 University of the WitwatersrandSouth Africa 25 works
  5. 5 Harvard UniversityUnited States 23 works
  6. 6 University of WashingtonUnited States 20 works
  7. 7 University of California San DiegoUnited States 20 works
  8. 8 Johns Hopkins MedicineUnited States 18 works
  9. 9 University of MiamiUnited States 18 works
  10. 10 Emory UniversityUnited States 18 works

Who are the leading researchers in HIV-related health complications and treatments?

The most-cited researchers publishing on HIV-related health complications and treatments include Roger Chou, Dan J. Stein and Kelly K. O’Brien.

  1. 1 Roger Chou United States 14k citations
  2. 2 Dan J. Stein South Africa 7.7k citations
  3. 3 Kelly K. O’Brien Canada 6.4k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is HIV-related health complications and treatments research done?

The largest centres of HIV-related health complications and treatments research in 2022–2025 are Chapel Hill (United States), London (United Kingdom), Beijing (China) and Baltimore (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Kampala and Cape Town.

Largest cities, 2022–2025

  1. 1 Chapel Hill United States 91 works
  2. 2 London United Kingdom 85 works
  3. 3 Beijing China 73 works
  4. 4 Baltimore United States 67 works
  5. 5 Boston United States 60 works
  6. 6 New York United States 58 works
  7. 7 Madrid Spain 57 works
  8. 8 Kampala Uganda 48 works
  9. 9 Paris France 42 works
  10. 10 San Francisco United States 42 works

Where it is the local speciality

  1. KampalaUG · 48.2 works28×
  2. Cape TownZA · 26.2 works16×
← less than its size predicts1×more →

Location quotient: how much more of its research is in HIV-related health complications and treatments than the world average.

See HIV-related health complications and treatments on the map

Where is the best place to study HIV-related health complications and treatments?

Among universities, judged by research, University of KwaZulu-Natal, Makerere University and University of the Witwatersrand score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 18.65%fractional works in this node (log) →share in the world top 10% →University of KwaZulu-Natal: 17, 20.8%Makerere University: 16, 23.8%University of the Witwatersrand: 25, 19.4%University of Gondar: 10, 23.0%London School of Hygiene & Tropical Medicine: 10, 21.2%University of Cape Town: 18, 20.8%University of California, San Francisco: 26, 17.3%University of North Carolina at Chapel Hill: 90, 2.8%Johns Hopkins University: 34, 17.8%Muhimbili University of Health and Allied Sciences: 10, 19.6%Makerere UniversityUniversity of GondarUniversity of KwaZul…University of the Wi…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 University of KwaZulu-NatalSouth Africa 63.220.8%11.9×17 +117.9%
2 Makerere UniversityUganda 60.323.8%22.1×16 +5.2%
3 University of the WitwatersrandSouth Africa 60.219.4%15.1×25 +38.1%
4 University of GondarEthiopia 59.823.0%16.6×10 +139.8%
5 London School of Hygiene & Tropical MedicineUnited Kingdom 59.721.2%16.4×10 +27.0%
6 University of Cape TownSouth Africa 58.220.8%13.8×18 +13.5%
7 University of California, San FranciscoUnited States 54.117.3%10.7×26 -8.1%
8 University of North Carolina at Chapel HillUnited States 53.32.8%13.5×90 +92.4%
9 Johns Hopkins UniversityUnited States 52.617.8%8.1×34 +21.0%
10 Muhimbili University of Health and Allied SciencesTanzania 49.219.6%57.6×10 -32.1%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is HIV-related health complications and treatments research growing?

Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are HIV-related health complications and treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.